• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.

作者信息

Zalutsky M R, Narula A S

机构信息

Department of Radiology, Duke University Medical Center, Durham, NC 27710.

出版信息

Int J Rad Appl Instrum A. 1987;38(12):1051-5. doi: 10.1016/0883-2889(87)90069-4.

DOI:10.1016/0883-2889(87)90069-4
PMID:2828275
Abstract

A procedure is described for the radioiodination of proteins using an iodinated derivative of N-succinimidyl 3-(tri-n-butylstannyl) benzoate (ATE). Adequate removal of unreacted ATE from [125I]ATE was necessary for optimal protein radioiodination. Labeling efficiencies of greater than 60% could be obtained after a 20 min incubation of goat IgG with [125I]ATE at 4 degrees C. Paired-label experiments with goat IgG labeled with 125I using ATE and 131I using Iodogen demonstrated that use of the ATE reagent for protein labeling significantly reduced (P less than 0.005) the thyroid uptake of radioiodine.

摘要

相似文献

1
A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
Int J Rad Appl Instrum A. 1987;38(12):1051-5. doi: 10.1016/0883-2889(87)90069-4.
2
Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.使用N-琥珀酰亚胺基3-(三正丁基锡基)苯甲酸酯中间体对单克隆抗体进行放射性卤化。
Cancer Res. 1988 Mar 15;48(6):1446-50.
3
N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
Nucl Med Biol. 1993 May;20(4):379-87. doi: 10.1016/0969-8051(93)90067-5.
4
Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.使用N-琥珀酰亚胺基3-(三正丁基锡基)苯甲酸酯进行放射性碘化的单克隆抗体的肿瘤定位增强及体内稳定性
Cancer Res. 1989 Oct 15;49(20):5543-9.
5
Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.马来酰亚胺基乙基3 -(三正丁基锡)马尿酸盐:一种用于蛋白质放射性药物以增强靶标选择性放射性定位的有用的放射性碘化试剂。
J Med Chem. 1994 Aug 5;37(16):2609-18. doi: 10.1021/jm00042a014.
6
Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.单克隆抗体嵌合体BR96的放射性碘化和生物素化优化:使用N-琥珀酰亚胺基-3-(三正丁基锡基)苯甲酸酯共轭物的间接标记
Cancer Biother Radiopharm. 1996 Jun;11(3):217-26. doi: 10.1089/cbr.1996.11.217.
7
Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.通过N-琥珀酰亚胺基2,4-二甲氧基-3-(三烷基锡基)苯甲酸酯对抗体进行放射性碘化。
Bioconjug Chem. 1990 Nov-Dec;1(6):387-93. doi: 10.1021/bc00006a004.
8
N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination.
Bioconjug Chem. 1991 Jan-Feb;2(1):50-6. doi: 10.1021/bc00007a009.
9
Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
Bioconjug Chem. 1990 Jul-Aug;1(4):269-73. doi: 10.1021/bc00004a007.
10
Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate.使用N-琥珀酰亚胺基三正丁基锡苯甲酸酯中间体对蛋白质进行砹化。
Int J Rad Appl Instrum A. 1988;39(3):227-32. doi: 10.1016/0883-2889(88)90176-1.

引用本文的文献

1
Late-stage labeling of diverse peptides and proteins with iodine-125.用碘-125对多种肽和蛋白质进行后期标记。
J Pharm Anal. 2025 Jul;15(7):101198. doi: 10.1016/j.jpha.2025.101198. Epub 2025 Jan 17.
2
Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies.减少放射性标记抗体对正常组织辐射的方法。
Pharmaceuticals (Basel). 2024 Apr 16;17(4):508. doi: 10.3390/ph17040508.
3
Precursor Reagent Hydrophobicity Affects Membrane Protein Footprinting.前体试剂疏水性会影响膜蛋白足迹分析。
J Am Soc Mass Spectrom. 2023 Dec 6;34(12):2700-2710. doi: 10.1021/jasms.3c00272. Epub 2023 Nov 15.
4
Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.《用于癌症治疗的α粒子发射放射性药物:治疗学发现的生物学基础、现状和未来展望》
Mol Imaging Biol. 2023 Dec;25(6):991-1019. doi: 10.1007/s11307-023-01857-y. Epub 2023 Oct 16.
5
Evaluation of an I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers.评估一种 I 标记的 HER2 特异性单域抗体片段用于治疗 HER2 表达型癌症的放射性药物疗法。
Sci Rep. 2022 Feb 22;12(1):3020. doi: 10.1038/s41598-022-07006-9.
6
Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies.水中亲核放射性卤素与芳基硼酸反应性的研究:获得一种用于抗体放射性碘化和砹化的高效单步方法。
Chem Sci. 2020 Nov 23;12(4):1458-1468. doi: 10.1039/d0sc05191h.
7
Observations on the Effects of Residualization and Dehalogenation on the Utility of -Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab.关于残留和脱卤化对用于内化抗体曲妥珠单抗放射性碘标记的 -琥珀酰亚胺酯酰化剂效用的影响的观察。
Molecules. 2019 Oct 30;24(21):3907. doi: 10.3390/molecules24213907.
8
Comparison of tumor‑targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2.直接和间接放射性碘标记的设计锚重复蛋白(DARPin)G3 变体对 HER2 分子成像的肿瘤靶向特性比较。
Int J Oncol. 2019 Apr;54(4):1209-1220. doi: 10.3892/ijo.2019.4712. Epub 2019 Feb 11.
9
d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution.用于蛋白质放射性碘标记的 D-氨基酸肽残留试剂:天冬氨酸取代谷氨酸的效果。
Molecules. 2018 May 20;23(5):1223. doi: 10.3390/molecules23051223.
10
Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies.用于抗体高效放射性碘化和砹化的双功能芳基碘鎓盐。
Bioorg Med Chem. 2017 Nov 1;25(21):5975-5980. doi: 10.1016/j.bmc.2017.09.022. Epub 2017 Sep 19.